{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:12:57Z","timestamp":1790871177803,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T00:00:00Z","timestamp":1473033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40801-016-0091-4","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T08:14:58Z","timestamp":1473063298000},"page":"393-399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (\u226575\u00a0years): A Monocentric Cohort Study of 61 Cases"],"prefix":"10.1007","volume":"3","author":[{"given":"Rachel","family":"Mourot-Cottet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Maloisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"S\u00e9verac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Tebacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Kaltenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques-Eric","family":"Gottenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Goichot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Sibilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Korganow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Herbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Andr\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,5]]},"reference":[{"key":"91_CR1","first-page":"1495","volume":"48","author":"W Schultz","year":"1922","unstructured":"Schultz W. Uber eigenartige Halserkrankungen. Dtsc Med Wochenschr. 1922;48:1495\u20137.","journal-title":"Dtsc Med Wochenschr"},{"key":"91_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/ehm.11.12","volume":"4","author":"E Andr\u00e8s","year":"2011","unstructured":"Andr\u00e8s E, Zimmer J, Mecili M, Weitten T, Alt M. Clinical presentation and management of drug-induced agranulocytosis. Expert Rev Hematol. 2011;4:143\u201351.","journal-title":"Expert Rev Hematol"},{"key":"91_CR3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E. Non-chemotherapy drug-induced agranulocytosis: a systematic review of case reports. Ann Intern Med. 2007;146:657\u201365.","journal-title":"Ann Intern Med"},{"key":"91_CR4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.1991.tb08042.x","volume":"79","author":"A Julia","year":"1991","unstructured":"Julia A, Olono M, Bueno J, Revilla E, Rosselo J, Petit J, et al. Drug-induced agranulocytosis: prognostic factors in a serie of 168 episodes. Br J Hematol. 1991;79:366\u201372.","journal-title":"Br J Hematol"},{"key":"91_CR5","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3324\/haematol.2014.110288","volume":"99","author":"J Palmblad","year":"2014","unstructured":"Palmblad J, Dufour C, Papadaki HA. How we diagnose neutropenia in the adult and elderly patient. Haematologica. 2014;99:1130\u20133. doi: 10.3324\/haematol.2014.110288 .","journal-title":"Haematologica"},{"key":"91_CR6","first-page":"325","volume":"28","author":"JE Kurtz","year":"1999","unstructured":"Kurtz JE, Andr\u00e8s E, Maloisel F, Kurtz-Illig V, Heitz D, Sibilia J, et al. Drug-induced agranulocytosis in elderly. A case series of 25 patients. Age. Aging. 1999;28:325\u20136.","journal-title":"Aging"},{"key":"91_CR7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0953-6205(02)00085-7","volume":"13","author":"E Andr\u00e8s","year":"2002","unstructured":"Andr\u00e8s E, Maloisel F, Kurtz JE, Kaltenbach G, Alt M, Weber JC, et al. Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature. Eur J Intern Med. 2002;13:324\u20138.","journal-title":"Eur J Intern Med"},{"key":"91_CR8","first-page":"257","volume":"33","author":"C B\u00e9nichou","year":"1993","unstructured":"B\u00e9nichou C, Solal-Celigny P. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting. Nouv Rev Fr Hematol. 1993;33:257\u201362.","journal-title":"Nouv Rev Fr Hematol"},{"key":"91_CR9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.therap.2016.02.009","volume":"71","author":"G Miremont-Salam\u00e9","year":"2016","unstructured":"Miremont-Salam\u00e9 G, Th\u00e9ophile H, Haramburu F, B\u00e9gaud B. Imputabilit\u00e9 en pharmacovigilance: de la m\u00e9thode fran\u00e7aise originelle aux m\u00e9thodes r\u00e9actualis\u00e9es. Th\u00e9rapie. 2016;71:171\u20138.","journal-title":"Th\u00e9rapie"},{"key":"91_CR10","first-page":"131","volume":"34","author":"V Bhatt","year":"2004","unstructured":"Bhatt V, Saleem A. Drug-induced neutropenia: pathophysiology, clinical features, and management. Ann Clin Lab Sci. 2004;34:131\u20137.","journal-title":"Ann Clin Lab Sci"},{"key":"91_CR11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/pds.2630020706","volume":"2","author":"DW Kaufman","year":"1993","unstructured":"Kaufman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agranulocytosis: an uptade of the International Agranulocytosis and Aplastic Anemia Study. Pharmacoepidemiol Drug Safety. 1993;2:525\u20139.","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"91_CR12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4269\/ajtmh.1999.60.573","volume":"60","author":"S Shapiro","year":"1999","unstructured":"Shapiro S, Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Thamprasit T, et al. Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg. 1999;60:573\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"91_CR13","doi-asserted-by":"crossref","unstructured":"van der Klauw MM, Goudsmit R, Halie MR, van\u2019t Veer MB, Herings RM, Wilson JH, et al. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med. 1999;159:369\u201374.","DOI":"10.1001\/archinte.159.4.369"},{"key":"91_CR14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1096-8652(199803)57:3<206::AID-AJH4>3.0.CO;2-Z","volume":"57","author":"MM Klauw Van der","year":"1998","unstructured":"Van der Klauw MM, Wilson JH, Stricker BH. Drug-associated agranulocytosis: 20\u00a0years of reporting in the Netherlands (1974\u20131994). Am J Hematol. 1998;57:206\u201311.","journal-title":"Am J Hematol"},{"key":"91_CR15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2125.2000.00132.x","volume":"49","author":"K Fattinger","year":"2000","unstructured":"Fattinger K, Roos M, Vergeres P, Holenstein C, Kind B, Masche U, et al. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of Internal Medicine. Br J Clin Pharmacol. 2000;49:158\u201367.","journal-title":"Br J Clin Pharmacol"},{"key":"91_CR16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00002512-200421070-00002","volume":"21","author":"E Andr\u00e8s","year":"2004","unstructured":"Andr\u00e8s E, Noel E, Kurtz JE. Henoun Loukili N, Kaltenbach G, Maloisel F. Life-threatening idiosyncratic drug-induced agranulocytosis in elderly patients. Drugs Aging. 2004;21:427\u201335.","journal-title":"Drugs Aging"},{"key":"91_CR17","first-page":"470","volume":"88","author":"F Maloisel","year":"2003","unstructured":"Maloisel F, Andr\u00e8s E, Kaltenbach G, Noel E. Prognostic factors of hematological recovery in nonchemotherapy drug-induced agranulocytosis. Haematologica. 2003;88:470\u20131.","journal-title":"Haematologica"},{"key":"91_CR18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0002-9343(02)01064-1","volume":"112","author":"E Andr\u00e8s","year":"2002","unstructured":"Andr\u00e8s E, Kurtz JE, Martin-Hunyadi C, Kaltenbach G, Alt M, Weber JC, et al. Non-chemotherapy drug-induced agranulocytosis in elderly patients: the effects of granulocyte colony-stimulating factor. Am J Med. 2002;112:460\u20134.","journal-title":"Am J Med"},{"key":"91_CR19","first-page":"2031","volume":"8","author":"A Sprikkelman","year":"1994","unstructured":"Sprikkelman A, de Wolf JT, Vellenga E. The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases. Leukemia. 1994;8:2031\u20136.","journal-title":"Leukemia"},{"key":"91_CR20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1592\/phco.19.4.299.30941","volume":"19","author":"MF Beauchesne","year":"1999","unstructured":"Beauchesne MF, Shalansky SJ. Nonchemotherapy drug-induced agranulocytosis: a review of 118 patients treated with colony-stimulating factors. Pharmacotherapy. 1999;19:299\u2013305.","journal-title":"Pharmacotherapy"},{"key":"91_CR21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/thy.1999.9.29","volume":"9","author":"S Fukata","year":"1999","unstructured":"Fukata S, Kuma K, Sugawara M. Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyro\u00efd. 1999;9:29\u201331.","journal-title":"Thyro\u00efd"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-016-0091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40801-016-0091-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-016-0091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:01:04Z","timestamp":1498341664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40801-016-0091-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,5]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["91"],"URL":"https:\/\/doi.org\/10.1007\/s40801-016-0091-4","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,5]]}}}